Literature DB >> 23204084

Forced eruption as an alternative to tooth extraction in long-term use of oral bisphosphonates: review, risks and technique.

Ami Smidt1, Mordekhai Lipovetsky-Adler, Eldad Sharon.   

Abstract

BACKGROUND: Osteonecrosis of the jaw (ONJ) is a painful condition secondary to bisphosphonate (BP) therapy. It occurs at a much higher rate in patients receiving intravenous (IV) versus oral BP treatment. BPs are prescribed in the treatment of bone diseases such as osteoporosis, multiple myeloma, cancer metastases and Paget disease. Patients' risk of developing ONJ is of concern to medical and dental teams alike and requires open communication between the disciplines. If dental surgery is indicated, it must be performed before commencement of IV BP therapy, and it should be considered for patients receiving oral BP therapy. However, the dental literature pertaining to the two therapeutic modalities stresses the low risk of ONJ's developing in patients receiving oral BP therapy (especially in the early stages) compared with that in patients receiving IV administration. CASE DESCRIPTION: The authors used forced eruption to extrude hemisected hopeless distal roots of first and second mandibular molars from within their alveolar sockets in a patient receiving long-term oral BP therapy. Just before the extraction, they placed orthodontic separating bands around the distal roots to further exfoliate the roots. This so-called bloodless extraction is an alternative treatment for patients at risk of developing ONJ. CLINICAL IMPLICATIONS: The combination of orthodontic extrusion and bloodless extraction is aimed at minimizing trauma and enhancing the health of the surrounding tissues in patients at risk of developing ONJ or when the patient refuses to undergo conventional tooth extraction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204084     DOI: 10.14219/jada.archive.2012.0091

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  2 in total

Review 1.  The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review.

Authors:  Julian Woolley; Oladapo Akintola; Julian Yates; Monica Diuana Calasans-Maia; Jose de Albuquerque Calasans-Maia; Iryna Kocherhina; Roberto Sacco
Journal:  Heliyon       Date:  2021-01-13

Review 2.  Current state of orthodontic patients under bisphosphonate therapy.

Authors:  Elena Krieger; Collin Jacobs; Christian Walter; Heinrich Wehrbein
Journal:  Head Face Med       Date:  2013-04-04       Impact factor: 2.151

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.